Keywords: AUC; area under the curve; CE; cost effectiveness; CEAC; cost-effectiveness acceptability curve; CI; confidence interval; DMSIC; Drug and Medical Supply Information Center; DRG; diagnosis-related group; DSA; deterministic sensitivity analysis; EGFR; epide
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
A randomised clinical trial of routine versus selective CT imaging in acute abdomen: Impact of patient age on treatment costs and hospital resource use
Keywords: AAP; acute abdominal pain; CEAC; cost-effectiveness acceptability curve; ED; emergency department; ICD-10; International Statistical Classification of Diseases and Related Health Problems, 10th revision; ICER; incremental cost-effectiveness ratio; LOS; le
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States
Keywords: Group B streptococcus (GBS); Maternal immunization; Neonatal sepsis; Neonatal meningitis; GBS vaccine; intrapartum antibiotic prophylaxis (IAP); cost-effectiveness analysis (CEA); United States; ABCs; Active Bacterial Core surveillance system; CDC; Center
Asthma and lower airway diseaseEconomic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study
Keywords: Asthma; cost-effectiveness analysis; decision analysis; evidence-based treatment; adherence; CEAC; Cost-effectiveness acceptability curve; GOAL; Gaining Optimal Asthma Control; ICER; Incremental cost-effectiveness ratio; ICS; Inhaled corticosteroid; PDC;
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
Keywords: MDD; major depressive disorder; HRQoL; health-related quality of life; GDP; gross domestic product; PPP; purchase power parity; CUA; cost-utility analysis; QALW; quality-adjusted life week; ICER; incremental cost-effectiveness ratio; CEAC; cost-effectiven